Koninklijke DSM Stock price Euronext Amsterdam
Equities
DSM
NL0000009827
Consumer Goods Conglomerates
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
114 EUR | +0.13% | -.--% | -.--% |
Mar. 12 | Quotes from Dutch companies on the worsening business climate | RE |
Mar. 12 | ASML's threat to leave uncovers deeper concerns in Netherlands Inc. | RE |
Sales 2024 * | 12.66B 13.65B | Sales 2025 * | 13.31B 14.35B | Capitalization | 27.96B 30.13B |
---|---|---|---|---|---|
Net income 2024 * | 448M 483M | Net income 2025 * | 753M 812M | EV / Sales 2024 * | 2.45 x |
Net Debt 2024 * | 3.02B 3.25B | Net Debt 2025 * | 2.7B 2.91B | EV / Sales 2025 * | 2.3 x |
P/E ratio 2024 * |
58.7
x | P/E ratio 2025 * |
36.5
x | Employees | 28,685 |
Yield 2024 * |
2.32% | Yield 2025 * |
2.3% | Free-Float | 25.76% |
Latest transcript on Koninklijke DSM
1 day | +0.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 89-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 23-08-31 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 23-01-31 | |
Thomas Leysen
CHM | Chairman | 63 | 23-01-31 |
Director/Board Member | 62 | 23-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.43% | 293 M€ | +12.08% | ||
1.13% | 18 M€ | +6.77% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 239B | |
+37.53% | 192B | |
-2.13% | 134B | |
+36.73% | 84.24B | |
+2.44% | 80.16B | |
-2.97% | 58.7B | |
-15.43% | 43.35B | |
+25.66% | 34.8B | |
+75.77% | 30.32B |
- Stock
- Equities
- Stock Danube AG
- Stock Koninklijke DSM - Euronext Amsterdam